Liquid Wart Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied at a time to ensure sufficient coverage of each wart. It is important to avoid application on the face or neck.

This procedure should be allowed to dry, and it may be repeated once or twice daily as necessary until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product due to the increased risk of complications. Application is also contraindicated on genital warts and warts located on the face, as well as on moles, birthmarks, and warts with hair growth, to prevent adverse effects. The product should not be applied to mucous membranes, as this may lead to irritation or injury. Additionally, use is contraindicated on irritated, infected, or reddened skin to avoid exacerbating these conditions.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it must be kept away from fire or flame. The bottle should be tightly capped and stored at room temperature, away from heat sources.

Individuals with diabetes or poor blood circulation should refrain from using this product. It is contraindicated for application on genital warts, warts located on the face, moles, birthmarks, and warts that have hair growing from them. Additionally, the product should not be applied to mucous membranes or on skin that is irritated, infected, or reddened.

While using this product, it is crucial to avoid contact with the eyes. In the event of accidental exposure to the eyes, it is recommended to flush the area with water for at least 15 minutes. Users should also take care to avoid inhaling vapors associated with the product.

If discomfort persists after use, it is advised to discontinue use and consult a healthcare professional. This product should be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it must be kept away from fire or flame. The bottle should be capped tightly and stored at room temperature, away from heat sources.

The product should not be used by individuals who are diabetic or have poor blood circulation. It is contraindicated for application on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes or on irritated, infected, or reddened skin.

While using this product, patients should avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

If discomfort persists, patients are advised to stop use and consult a healthcare professional. Furthermore, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Liquid Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of Liquid Wart Remover (salicylic acid liquid) during pregnancy. Consequently, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits of treatment during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Consequently, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the potential risks to breastfed infants are not clearly defined. It is advisable to consider the benefits of breastfeeding alongside the unknowns related to the medication's excretion in breast milk and its potential impact on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any overdosage incidents to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product should not be used by individuals who are diabetic or have poor blood circulation.

Patients should be cautioned against using the product on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, the product should not be applied to mucous membranes or on skin that is irritated, infected, or reddened.

Healthcare providers should instruct patients to discontinue use and consult a doctor if discomfort persists. While using the product, patients should be reminded to avoid contact with their eyes; in the event of contact, they should flush the eye with water for 15 minutes. Furthermore, patients should be advised to avoid inhaling vapors while using the product.

Storage and Handling

The product is supplied in a tightly capped bottle, which must be stored at room temperature, specifically between 20° to 25°C (68° - 77°F). It is essential to keep the container closed tightly to prevent solidification. Additionally, the product should be kept away from heat sources and any open flames to ensure safety and integrity. For optimal storage conditions, it is recommended to place the product in a cool location, away from fire or flame.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Liquid Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)